Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 135
Selected: 0
NCT IDTitle
NCT04370925Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
NCT02605265Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
NCT07217600Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
NCT05687851Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
NCT05304741The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
NCT06498154Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy
NCT04830267The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC
NCT04768270The Culture of Ovarian Cancer Organoids and Drug Screening
NCT07266350A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer
NCT05717751Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer
NCT05273944Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
NCT06238284HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
NCT06830304A Multilevel Intervention to Improve Uptake of Gastrointestinal Cancer Screening: a Cluster Randomized Clinical Trial
NCT04542356Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer
NCT03761550pMDT in Thoracic Surgery--The Process Implementation Stage
NCT05907447A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT04409860The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
NCT03366883Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT04880746Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study
NCT06550739Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT05029141New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NCT06180174Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
NCT05401175Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer
NCT04723875Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
NCT05548348First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation
NCT02123381Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
NCT06279104A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06524427Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NCT05351346Genotype-guided Treatment in DLBCL
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
NCT05776407Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
NCT07029464Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis
NCT06078930Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
NCT04303247CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL
NCT06022978Submucosal Saline Injection Followed by Endoscopic Ultrasound
NCT05551208Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
NCT04286503The Clinical Study of Carrimycin on Treatment Patients With COVID-19
NCT06317610Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
NCT05799469Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
NCT05780372Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT05759572Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
NCT04998760A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )
NCT06055166A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors
NCT05290961The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening
NCT03955367Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT05473728Epidemiology Study and Risk Factor Analysis on Chronic Post-surgical Pain After Video-assisted Thoracic Surgery
NCT04588090A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.
NCT06612814PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer